Clinical challenges of genotype positive (+)phenotype negative (-) family members in hypertrophic cardiomyopathy

American Journal of Cardiology

Volumn 107, Issue 4, 2011, Pages 604-608

  Maron, Barry J ^a   Yeates, Laura ^b   Semsarian, Christopher ^b,c,d  

^a MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

^b CENTENARY INSTITUTE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; FAMILY; GENETICS; GENOTYPE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRIORITY JOURNAL;

EID: 79551682679     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.10.022     Document Type: Note

References (32)

1. R. Alcalai, J.G. Seidman, and C.E. Seidman Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics J Cardiovasc Electrophysiol 19 2008 104 110
2. J.G. Seidman, and C. Seidman The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms Cell 104 2001 557 567
3. B.J. Maron, J.J. Doerer, T.S. Haas, D.M. Tierney, and F.O. Mueller Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006 Circulation 119 2009 1085 1092
4. M.S. Maron, B.J. Maron, C. Harrigan, J. Buros, C.M. Gibson, I. Olivotto, L. Biller, J.R. Lesser, J.E. Udelson, W.J. Manning, and E. Appelbaum Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance J Am Coll Cardiol 54 2009 220 228
5. B.J. Maron, C.E. Seidman, M.J. Ackerman, J.A. Towbin, M.S. Maron, S.R. Ommen, R.A. Nishimura, and B.J. Gersh Whats in a name? Dilemmas in nomenclature characterizing hypertrophic cardiomyopathy and left ventricular hypertrophy Circ Cardiovasc Genet 2 2009 81 86
6. H.G. Klues, A. Schiffers, and B.J. Maron Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients J Am Coll Cardiol 26 1995 1699 1708
7. J. Ingles, A. Doolan, C. Chiu, J. Seidman, C. Seidman, and C. Semsarian Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling J Med Genet 42 2005 e59
8. B.J. Maron Hypertrophic cardiomyopathy: a systematic review JAMA 287 2002 1308 1320
9. B.J. Maron, W.J. McKenna, G.K. Danielson, L.J. Kappenberger, H.J. Kuhn, C.E. Seidman, P.M. Shah, W.H. Spencer III, P. Spirito, F.J. Ten Cate, and E.D. Wigle American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Eur Heart J 24 2003 1965 1991 (Pubitemid 37336422)
10. B.J. Maron, and C.Y. Ho Hypertrophic cardiomyopathy without hypertrophy: an emerging pre-clinical subgroup composed of genetically affected family members JACC Cardiovasc Imaging 2 2009 65 68
11. W.J. McKenna, J.T. Stewart, P. Nihoyannopoulos, F. McGinty, and M.J. Davies Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass Br Heart J 63 1990 287 290
12. B.J. Maron, H. Niimura, S.A. Casey, M.K. Soper, G.B. Wright, J.G. Seidman, and C.E. Seidman Development of left ventricular hypertrophy in adults with hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C mutations J Am Coll Cardiol 38 2001 315 321
13. J.M. Lind, C. Chiu, and C. Semsarian Genetic basis of hypertrophic cardiomyopathy Expert Rev Cardiovasc Ther 4 2006 927 934
14. M. Kelly, and C. Semsarian Multiple mutations in genetic cardiovascular disease: a marker of disease severity? Circ Cardiovasc Genet 2 2009 182 190
15. C.Y. Ho, N.K. Sweitzer, B. McDonough, B.J. Maron, S.A. Casey, J.G. Seidman, C.E. Seidman, and S.D. Solomon Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy Circulation 105 2002 2992 2997
16. T. Germans, A.A.M. Wilde, P.A. Dijkmans, W. Chai, O. Kamp, Y.M. Pinto, and A.C. van Rossum Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations J Am Coll Cardiol 48 2006 2518 2523
17. Maron MS, Lesser RJ, Maron BJ. Massive left ventricular hypertrophy in hypertrophic cardiomyopathy significantly underestimated by echocardiography but identified by cardiovascular magnetic resonance: implications for management strategies. Am J Cardiol. In press.
18. J.V. Montgomery, K.M. Harris, S.A. Casey, A.G. Zenovich, and B.J. Maron Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy Am J Cardiol 96 2005 270 275
19. C.J. McLeod, M.J. Ackerman, R.A. Nishimura, A.J. Tajik, B.J. Gersh, and S.R. Ommen Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram J Am Coll Cardiol 54 2009 229 233
20. B.J. Maron Sudden death in young athletes N Engl J Med 349 2003 1064 1075
21. A. Pelliccia, D.P. Zipes, and B.J. Maron Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities J Am Coll Cardiol 52 2008 1990 1996
22. B.J. Maron, and D.P. Zipes 36th Bethesda Conference: eligibility recommendations for competitive athletes with cardiovascular abnormalities J Am Coll Cardiol 45 2005 1312 1375
23. A. Pelliccia, R. Fagard, H.H. Bjornstad, A. Anastassakis, E. Arbustini, D. Assanelli, A. Biffi, M. Borjesson, F. Carr, D. Corrado, P. Delise, U. Dorwarth, A. Hirth, H. Heidbuchel, E. Hoffmann, K.P. Mellwig, N. Panhuyzen-Goedkoop, A. Pisani, E.E. Solberg, F. van-Buuren, L. Vanhees, C. Blomstrom-Lundqvist, A. Deligiannis, D. Dugmore, M. Glikson, P.I. Hoff, A. Hoffmann, E. Hoffmann, D. Horstkotte, J.E. Nordrehaug, J. Oudhof, W.J. McKenna, M. Penco, S. Priori, T. Reybrouck, J. Senden, A. Spataro, and G. Thiene Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology Eur Heart J 26 2005 1422 1445
24. B.J. Maron, P. Spirito, W.-K. Shen, T.S. Haas, F. Formisano, M.S. Link, A.E. Epstein, A.K. Almquist, J.P. Daubert, T. Lawrenz, G. Boriani, N.A. Estes III, S. Favale, M. Piccininno, S.L. Winters, M. Santini, S. Betocchi, F. Arribas, M.V. Sherrid, G. Buja, C. Semsarian, and P. Bruzzi Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy JAMA 298 2007 405 412 (Pubitemid 47124061)
25. B.J. Maron Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy Circulation 121 2010 445 456
26. J.M. Bos, B.J. Maron, M.J. Ackerman, T.S. Haas, P. Sorajja, R.A. Nishimura, B.J. Gersh, and S.R. Ommen Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy Am J Cardiol 106 2010 1481 1486
27. B.J. Maron, and P. Spirito Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy J Cardiovasc Electrophysiol 19 2008 1118 1126
28. I. Christiaans, R.H. Lekanne dit Deprez, I.M. van Langen, and A.A. Wilde Ventricular fibrillation in MYH7-related hypertrophic cardiomyopathy before onset of ventricular hypertrophy Heart Rhythm 6 2009 1366 1369
29. J.A. Panza, and B.J. Maron Relation of electrocardiographic abnormalities to evolving left ventricular hypertrophy in hypertrophic cardiomyopathy during childhood Am J Cardiol 63 1989 1258 1265
30. M. Michels, O.I. Soliman, J. Phefferkorn, Y.M. Hoedemaekers, M.J. Kofflard, D. Dooijes, D. Majoor-Krakauer, and F.J. Ten Cate Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers Eur Heart J 30 2009 2593 2598
31. B. Strijack, V. Ariyarajah, R. Soni, D.S. Jassal, C.R. Greenberg, R. McGregor, and M. Morris Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype J Cardiovasc Magn Reson 10 2008 58
32. B.J. Maron, J.G. Seidman, and C.E. Seidman Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy J Am Coll Cardiol 44 2004 2125 2132